Composite medicine for treating cholecystitis and preparation method thereof

A technology of cholecystitis and medicine, applied in the field of combination medicine for treating cholecystitis and its preparation, can solve problems such as inability to cure cholecystitis and increase pain, and achieve the goal of regulating gas and blood circulation in the digestive system, promoting the effect, and improving the treatment effect Effect

Inactive Publication Date: 2018-09-21
肖耀刚
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a combination medicine for treating cholecystitis and its preparation method, which has the advantages of qu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] This example provides a combination drug for the treatment of cholecystitis, including 5 parts of modified metoclopramide, 0.2 part of modified cimetidine, 0.25 part of modified oxytetracycline, 0.1 part of vitamin C, and 3.4 parts of vitamin K 3 parts of licorice, 4 parts of fern grass.

[0042] Wherein, the modified metoclopramide is formed by mixing metoclopramide, benzamide, and dopamine D2 in a ratio of 2:1:1, and its preparation method is as follows:

[0043] S1: first add 2 parts of metoclopramide to an appropriate amount of water, and heat to dissolve;

[0044] S2: add 1 part of benzamide, and keep warm at 80°C for 20 minutes;

[0045] S3: Finally, add 1 part of dopamine D2 and stir at 60 r / min.

[0046] The preparation method of described modified cimetidine is as follows:

[0047] S1: First add Tagamet to an appropriate amount of water and heat to dissolve;

[0048] S2: Add cimetidine again, and keep warm at 50°C for 30 minutes;

[0049] S3: Then heat up ...

Embodiment 2

[0059] This example provides a combination medicine for treating cholecystitis, comprising 6 parts of modified metoclopramide, 0.4 part of modified cimetidine, 0.5-1 part of modified oxytetracycline, 0.2 parts of vitamin C, vitamin K4 4 parts of licorice, 5 parts of phoenix grass.

[0060] Wherein, the modified metoclopramide is formed by mixing metoclopramide, benzamide, and dopamine D2 in a ratio of 2:1:1, and its preparation method is as follows:

[0061] S1: first add 2 parts of metoclopramide to an appropriate amount of water, and heat to dissolve;

[0062] S2: add 1 part of benzamide, and keep warm at 80°C for 20 minutes;

[0063] S3: Finally, add 1 part of dopamine D2 and stir at 60 r / min.

[0064] The preparation method of described modified cimetidine is as follows:

[0065] S1: First add Tagamet to an appropriate amount of water and heat to dissolve;

[0066] S2: Add cimetidine again, and keep warm at 50°C for 30 minutes;

[0067] S3: Then heat up to 100°C to ev...

Embodiment 3

[0077] This example provides a combination drug for the treatment of cholecystitis, including 7 parts of modified metoclopramide, 0.6 parts of modified cimetidine, 0.75 parts of modified oxytetracycline, 0.3 parts of vitamin C, and 4.5 parts of vitamin K 6 parts of licorice, 7 parts of fern grass.

[0078] Wherein, the modified metoclopramide is formed by mixing metoclopramide, benzamide, and dopamine D2 in a ratio of 2:1:1, and its preparation method is as follows:

[0079] S1: first add 2 parts of metoclopramide to an appropriate amount of water, and heat to dissolve;

[0080] S2: add 1 part of benzamide, and keep warm at 80°C for 20 minutes;

[0081] S3: Finally, add 1 part of dopamine D2 and stir at 60 r / min.

[0082] The preparation method of described modified cimetidine is as follows:

[0083] S1: First add Tagamet to an appropriate amount of water and heat to dissolve;

[0084] S2: Add cimetidine again, and keep warm at 50°C for 30 minutes;

[0085] S3: Then heat ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a composite medicine for treating cholecystitis and a preparation method thereof. The composite medicine for treating the cholecystitis is prepared from 5 to 10 parts of modified metoclopramide, 0.2 to 1 part of modified cimetidine, 0.25 to 1 part of modified oxytetracycline, 0.1 to 0.5 part of vitamin C, 3.4 to 5.5 parts of vitamin K, 3 to 9 parts of liquorice root and 4 to 8 parts of herba pteridis multifidae, wherein the modified metoclopramide is prepared by mixing methoxychlorprocainamide, benzamide and dopamine D2 according to the ratio of 2 to 1 to 1; the modified cimetidine is one or more of tagamet, cimetidine and cimitidine. The composite medicine can be used for enabling blood circulation physiology of a patient to reach a molecularization level; the treatment effect is remarkably improved, the treatment time is greatly shortened, pains of the patient are reduced and the cost is relatively low; the composite medicine is convenient to use and carry andhas a small side effect; the probability that the treatment effect is good is 96 percent, and is improved by 8 percent when being compared with the probability that he treatment effect is good of common medicines in the market; the composite medicine has wide clinical application and can provide better services for health of people.

Description

technical field [0001] The invention relates to the technical field of medical drugs, in particular to a combined drug for treating cholecystitis and a preparation method thereof. Background technique [0002] Compound gasxisu is based on the physiological and pathological analysis of the transformation of cholecystitis into gallstones. Gallstones are produced after bile acidification (PH) decreases. After the acidification of bile, the calcium ions and phosphorus ions supplied by food combine with the bile acid to form stones. The choice of medicine should first benefit the choleresis, neutralize the excess floating acid, acidic compounds such as carbonic acid, and promote arterial and venous blood circulation. It must be available, and it must also be used to regulate Qi, anticoagulant drugs, anti-inflammatory drugs, etc. Currently, Xiaoyan Lidan Tablets on the market have certain effects in treating gallbladder, but they cannot be completely cured. Using Liver Tablets to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/122A61K31/137A61K31/166A61K31/375A61K31/4164A61K31/65A61K36/484A61P1/16
CPCA61K31/166A61K31/122A61K31/137A61K31/375A61K31/4164A61K31/65A61K36/12A61K36/484A61K2236/331A61K2236/39A61K2236/51A61P1/16A61K2300/00
Inventor 肖耀刚
Owner 肖耀刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap